Researchers inject retinal support cells derived from human embryonic stem cells into the eyes of four men with macular degeneration, bolstering evidence of the experimental treatment’s safety. A ...

Among the forms of monogenic macular degeneration, the most common is Stargardt disease. This disease is caused by mutations in the ATP-binding cassette transporter alpha 4 subunit (ABCA4) gene, ...

Scientists enhance eye imaging with AI, achieving high-resolution views of retinal cells, potentially revolutionizing disease ...

According to the NIH (2023), the projected prevalence of Stargardt macular degeneration stands at approximately 1 in 6,500 individuals within the United States. In 2023, the United States had the ...

Gildeuretinol is currently being evaluated in clinical trials for the treatment of Stargardt disease and for geographic atrophy secondary to age-related macular degeneration. Gildeuretinol has ...

Diseases such as neovascular age-related macular degeneration (nAMD), myopic maculopathy ... of their optic nerves and posterior staphylomas. Stargardt disease is a common form of inherited ...

secondary to dry age-related macular degeneration. The company also released encouraging data from a Phase 1/2 study for OCU410 in the treatment of Stargardt disease and a Phase 1/2 study of ...

Macular degeneration is the most common cause of age-related vision loss in older adults. In a healthy eye, light travels through the pupil and hits the retina, the inner back layer of your eye.

One of the artists is Albert Schmiege. Schmiege experiences poor depth perception, no central vision and color blindness due to Stargardt macular degeneration, according to biography in the gallery.